首页> 美国卫生研究院文献>Therapeutics and Clinical Risk Management >The role of inflammation in cardiovascular diseases: the predictive value of neutrophil–lymphocyte ratio as a marker in peripheral arterial disease
【2h】

The role of inflammation in cardiovascular diseases: the predictive value of neutrophil–lymphocyte ratio as a marker in peripheral arterial disease

机译:炎症在心血管疾病中的作用:中性粒细胞-淋巴细胞比率作为外周动脉疾病标志物的预测价值

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Peripheral arterial disease (PAD) is an important manifestation of atherosclerosis, with increasing prevalence worldwide. A growing body of evidence shows that the systemic inflammatory response is closely related to the development, progression, and prognosis of atherosclerosis. In the last decade, several studies have suggested the role of measured inflammatory biomarkers as predictors of severity and prognosis in PAD in an effort to stratify the risk of these patients, to improve treatment selection, and to predict the results after interventions. A simple inflammatory marker, more available than any other, is the neutrophil–lymphocyte ratio (NLR), which can be easily obtained in clinical practice, based on the absolute count of neutrophils and lymphocytes from the differential leukocytes count. Many researchers evaluated vigorously the NLR as a potential prognostic biomarker predicting pathological and survival outcomes in patients with atherosclerosis. In this work, we aim to present the role of NLR as a prognostic marker in patients with PAD through a thorough review of the literature.
机译:周围动脉疾病(PAD)是动脉粥样硬化的重要表现,在世界范围内患病率正在上升。越来越多的证据表明,全身炎症反应与动脉粥样硬化的发生,发展和预后密切相关。在过去的十年中,数项研究表明,炎症生物标志物可作为PAD严重程度和预后的预测指标,以分层这些患者的风险,改善治疗选择并预测干预后的结果。中性粒细胞-淋巴细胞比率(NLR)是比任何其他方法都更容易获得的简单炎症标志物,根据中性白细胞和淋巴细胞的绝对计数(来自差异性白细胞计数),可以在临床实践中轻松获得。许多研究人员对NLR进行了强有力的评估,将其作为预测动脉粥样硬化患者病理和生存结果的潜在预后生物标志物。在这项工作中,我们旨在通过全面回顾文献介绍NLR在PAD患者中作为预后指标的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号